Cite
HARVARD Citation
Klümper, N. et al. (2021). C‐reactive protein flare‐response predicts long‐term efficacy to first‐line anti‐PD‐1‐based combination therapy in metastatic renal cell carcinoma. Clinical & translational immunology. 10 (12), p. n/a. [Online].